These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12107151)

  • 81. Alterations of susceptibility of Pseudomonas aeruginosa by overproduction of multidrug efflux systems, MexAB-OprM, MexCD-OprJ, and MexXY/OprM to carbapenems: substrate specificities of the efflux systems.
    Okamoto K; Gotoh N; Nishino T
    J Infect Chemother; 2002 Dec; 8(4):371-3. PubMed ID: 12525903
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy.
    Le Thomas I; Couetdic G; Clermont O; Brahimi N; Plésiat P; Bingen E
    J Antimicrob Chemother; 2001 Oct; 48(4):553-5. PubMed ID: 11581237
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa.
    Vestergaard M; Paulander W; Marvig RL; Clasen J; Jochumsen N; Molin S; Jelsbak L; Ingmer H; Folkesson A
    Int J Antimicrob Agents; 2016 Jan; 47(1):48-55. PubMed ID: 26597931
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
    Schweizer HP
    Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
    Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
    J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2242-6. PubMed ID: 10952562
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
    Purssell A; Poole K
    Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
    Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Biochemical Reconstitution and Characterization of Multicomponent Drug Efflux Transporters.
    Picard M; Tikhonova EB; Broutin I; Lu S; Verchère A; Zgurskaya HI
    Methods Mol Biol; 2018; 1700():113-145. PubMed ID: 29177829
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The outer membrane component of the multidrug efflux pump from Pseudomonas aeruginosa may be a gated channel.
    Yoshihara E; Maseda H; Saito K
    Eur J Biochem; 2002 Oct; 269(19):4738-45. PubMed ID: 12354104
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa.
    Germ M; Yoshihara E; Yoneyama H; Nakae T
    Biochem Biophys Res Commun; 1999 Aug; 261(2):452-5. PubMed ID: 10425205
    [TBL] [Abstract][Full Text] [Related]  

  • 96. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
    Puzari M; Chetia P
    World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ.
    Hay T; Fraud S; Lau CH; Gilmour C; Poole K
    PLoS One; 2013; 8(2):e56858. PubMed ID: 23441219
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Induction of Pseudomonas syringae pv. tomato DC3000 MexAB-OprM multidrug efflux pump by flavonoids is mediated by the repressor PmeR.
    Vargas P; Felipe A; Michán C; Gallegos MT
    Mol Plant Microbe Interact; 2011 Oct; 24(10):1207-19. PubMed ID: 21649511
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Efflux pump regulatory genes mutations in multidrug resistance Pseudomonas aeruginosa isolated from wound infections in Isfahan hospitals.
    Vaez H; Faghri J; Isfahani BN; Moghim S; Yadegari S; Fazeli H; Moghofeei M; Safaei HG
    Adv Biomed Res; 2014; 3():117. PubMed ID: 24949288
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Evaluation of Antibiotic Resistance and
    Moosavi SM; Pouresmaeil O; Zandi H; Emadi S; Akhavan F; Torki A; Astani A
    Rep Biochem Mol Biol; 2020 Jul; 9(2):140-146. PubMed ID: 33178862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.